Free Trial

Better Therapeutics (BTTX) Insider Trading & Ownership

→ top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad)
Free BTTX Stock Alerts
$0.0078
0.00 (0.00%)
(As of 04/24/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Better Therapeutics (NASDAQ:BTTX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
51.40%
Number Of
Insiders Buying
(Last 12 Months)
5
Amount Of
Insider Buying
(Last 12 Months)
$1.24 M
Number Of
Insiders Selling
(Last 12 Months)
0
Get BTTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Better Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

BTTX Insider Buying and Selling by Quarter

Ad Traders Agency
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.
Click here now for the full details of this stock that’s set to rocket in the AI revolution…

Better Therapeutics Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/27/2023Andrew J ArmaninoDirectorBuy274,010$0.73$200,027.30  
7/27/2023David P PerryChairmanBuy1,233,045$0.73$900,122.85  
7/27/2023Frank KarbeCEOBuy137,005$0.73$100,013.65  
7/27/2023Mark A BermanInsiderBuy54,802$0.73$40,005.46  
5/16/2023Elder GrangerDirectorBuy600$0.87$522.00  
(Data available from 1/1/2013 forward)

BTTX Insider Trading Activity - Frequently Asked Questions

Who is on Better Therapeutics's Insider Roster?

The list of insiders at Better Therapeutics includes Andrew J Armanino, David P Perry, Elder Granger, Frank Karbe, Geoffrey M Parker, Kevin J Appelbaum, Mark A Berman, Mark Heinen, and Risa J Lavizzo-Mourey. Learn more on insiders at BTTX.

What percentage of Better Therapeutics stock is owned by insiders?

51.40% of Better Therapeutics stock is owned by insiders. Learn more on BTTX's insider holdings.

Which Better Therapeutics insiders have been buying company stock?

The following insiders have purchased BTTX shares in the last 24 months: Andrew J Armanino ($200,027.30), David P Perry ($900,122.85), Elder Granger ($522.00), Frank Karbe ($403,301.33), Geoffrey M Parker ($284,734.60), Mark A Berman ($40,005.46), and Mark Heinen ($58,095.67).

How much insider buying is happening at Better Therapeutics?

Insiders have purchased a total of 2,351,065 BTTX shares in the last 24 months for a total of $1,886,809.21 bought.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:BTTX) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners
He Is Giving Away Bitcoin
Crypto Swap Profits
Bitcoin Rockets To Record High But Buy THIS Instead
Paradigm Press
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
Traders Agency
Urgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!
American Alternative
Emergency: Biden's $20 Trillion Mistake Could Cost YOU!
GoldenCrest Metals
Fed launches fourth dollar overhaul
Stansberry Research
1970’s computer coder issues shocking A.I. warning
TradeSmith
Exposed: 10 CENT Crypto to Explode April 20th?
True Market Insiders